Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Candida | 3 | 2023 | 24 | 1.490 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2017 | 59 | 1.020 |
Why?
|
| Mass Screening | 3 | 2017 | 242 | 0.930 |
Why?
|
| Mycoses | 1 | 2022 | 8 | 0.820 |
Why?
|
| Candidiasis | 1 | 2021 | 15 | 0.780 |
Why?
|
| Drug Resistance, Fungal | 2 | 2021 | 13 | 0.720 |
Why?
|
| Candidemia | 2 | 2021 | 13 | 0.720 |
Why?
|
| Disease Outbreaks | 2 | 2020 | 111 | 0.650 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 2 | 0.570 |
Why?
|
| Fungi | 1 | 2017 | 4 | 0.570 |
Why?
|
| HIV Infections | 5 | 2022 | 4946 | 0.560 |
Why?
|
| Azoles | 1 | 2016 | 3 | 0.530 |
Why?
|
| Antigens, Fungal | 1 | 2016 | 9 | 0.520 |
Why?
|
| Cryptococcosis | 1 | 2016 | 17 | 0.520 |
Why?
|
| Sporotrichosis | 1 | 2015 | 2 | 0.510 |
Why?
|
| Sporothrix | 1 | 2015 | 2 | 0.510 |
Why?
|
| Sentinel Surveillance | 1 | 2016 | 110 | 0.500 |
Why?
|
| Mining | 1 | 2015 | 41 | 0.490 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2017 | 194 | 0.490 |
Why?
|
| Coinfection | 1 | 2017 | 268 | 0.470 |
Why?
|
| Cryptococcus | 1 | 2012 | 10 | 0.410 |
Why?
|
| Meningitis, Cryptococcal | 1 | 2012 | 16 | 0.410 |
Why?
|
| Humans | 10 | 2023 | 14077 | 0.360 |
Why?
|
| Infant, Newborn | 4 | 2023 | 1410 | 0.310 |
Why?
|
| Adult | 6 | 2021 | 5664 | 0.300 |
Why?
|
| Middle Aged | 5 | 2021 | 3425 | 0.300 |
Why?
|
| South Africa | 7 | 2023 | 7312 | 0.270 |
Why?
|
| Aged | 3 | 2021 | 1650 | 0.260 |
Why?
|
| Child | 3 | 2023 | 2180 | 0.250 |
Why?
|
| Whole Genome Sequencing | 2 | 2021 | 40 | 0.240 |
Why?
|
| Adolescent | 4 | 2021 | 2858 | 0.230 |
Why?
|
| Child, Preschool | 2 | 2021 | 1675 | 0.230 |
Why?
|
| Young Adult | 3 | 2021 | 2357 | 0.230 |
Why?
|
| Male | 5 | 2021 | 6489 | 0.230 |
Why?
|
| Infant | 2 | 2021 | 2145 | 0.220 |
Why?
|
| Genome, Fungal | 1 | 2021 | 4 | 0.200 |
Why?
|
| Antifungal Agents | 1 | 2021 | 40 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 274 | 0.190 |
Why?
|
| Phylogeny | 1 | 2021 | 231 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 184 | 0.180 |
Why?
|
| Hospitals | 2 | 2023 | 102 | 0.180 |
Why?
|
| Meat Products | 1 | 2020 | 2 | 0.170 |
Why?
|
| Foodborne Diseases | 1 | 2020 | 6 | 0.170 |
Why?
|
| Listeria monocytogenes | 1 | 2020 | 6 | 0.170 |
Why?
|
| Listeriosis | 1 | 2020 | 8 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2023 | 1131 | 0.150 |
Why?
|
| Gold | 1 | 2015 | 37 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 449 | 0.120 |
Why?
|
| Survival Rate | 1 | 2012 | 96 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1377 | 0.090 |
Why?
|
| Incidence | 1 | 2012 | 655 | 0.090 |
Why?
|
| Female | 3 | 2020 | 8751 | 0.080 |
Why?
|
| Malaria, Falciparum | 1 | 2005 | 39 | 0.060 |
Why?
|
| Klebsiella pneumoniae | 1 | 2023 | 36 | 0.050 |
Why?
|
| Bacteria | 1 | 2023 | 46 | 0.050 |
Why?
|
| Product Recalls and Withdrawals | 1 | 2020 | 1 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 1 | 2020 | 11 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2020 | 89 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 464 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 507 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 1815 | 0.030 |
Why?
|
| HIV-1 | 1 | 2020 | 1239 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2005 | 132 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 171 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2005 | 939 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1149 | 0.010 |
Why?
|
| Risk Factors | 1 | 2005 | 1431 | 0.010 |
Why?
|